We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Unani Formulation Habb-e-Suranjan: A Treasure of Biological Activities.
- Authors
Ahemad, Ansari Imtiyaz Ahmed Tufail; Aejazuddin, Qazi Majaz Ahamad; Khan, G. J.; Alsayari, Abdulrhman; Wahab, Shadma; Khan, Sharuk L.; Akter, Noor Jahan; Islam, Md. Rezaul; Roy, Arpita; Islam, Fahadul
- Abstract
Habb-e-Suranjan (HES), an Unani formulation, has been studied for its anti-inflammatory properties in both in vitro and in vivo experiments. HES is recommended for arthritis, gout, and joint pain. The current endeavor is an attempt to put it to the test and verify its efficacy scientifically. It was tested for DPPH, hydroxyl, and nitric oxide scavenging activities. It was shown that HES had the greatest TAC and FRAC values when compared to catechin and ascorbic acid. HES exhibited DPPH and hydroxyl radical scavenging activity that was dose-dependent. Incubation of sodium nitroprusside solutions in PBS at 25°C for 150 min resulted in the production of nitric oxide. Nitric oxide production was effectively decreased by HES. Anti-inflammatory medications boosted the migration of PMN cells toward the chemoattractant FMLP in an agarose experiment of PMN chemotaxis. In carrageenan-induced rat paw edema, in the HES-treated group, paw thickness was 3.021 ± 0.084 at t = 0 , but it showed an increase in paw inflammation after one hour, i.e., 3.195 ± 0.082 cm which again showed a decrease in paw thickness up to 4th hour, i.e., 3.018 ± 0.078 , 2.98 ± 0.032 , and 2.684 ± 0.061 at t = 2 , 3, and 4, respectively. It showed again getting back to the normal thickness of paw at t = 24 hrs, i.e., 3.029 ± 0.118 cm. It is concluded that the formulation is potent enough and can be used effectively for the treatment of inflammation and associated health issues. Moreover, there is much scope to evaluate its effectiveness using different in vitro and in vivo models.
- Subjects
PHYTOTHERAPY; THERAPEUTIC use of vitamin C; DRUG therapy for arthritis; DRUG efficacy; POLYSACCHARIDES; IN vitro studies; ARAB medicine; FLAVONOIDS; IN vivo studies; ANTI-inflammatory agents; TIME; INFLAMMATION; ANIMAL experimentation; CULTURES (Biology); PHARMACEUTICAL chemistry; FREE radical scavengers; NITRIC oxide; EDEMA
- Publication
BioMed Research International, 2022, p1
- ISSN
2314-6133
- Publication type
Article
- DOI
10.1155/2022/1640193